Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 811 results for "pasi"

Travelling to the Philippines? Here's why you should check out...

Food fairs, snake dances, tribal contests and more. There's a lot to discover at this festival, in the province of Ilolio DNA, 1 week ago

26 images for pasi

Finland Times, 5 days ago
Finland Times, 1 week ago
Borneo Post Online, 4 days ago
4 Traders, 6 days ago
Seeking Alpha, 1 week ago
Seeking Alpha, 1 week ago
Zimbabwe Chronicle, 3 weeks ago
Zimbabwe Chronicle, 3 weeks ago
Zimbabwe Herald, 3 weeks ago
The Rakyat Post, 1 month ago

Pasi defends tax on hotel accommodation

The Zimbabwe Revenue Authority (ZIMRA) says tax on hotel accommodation for foreign guests is not unique to Zimbabwe but is common all over the world including in neighbouring countries such as South Africa and Zambia. Zimra Commissioner-General Mr ...
 Zimbabwe Herald3 weeks ago
4 Traders

New Novartis data show more Cosentyx-treated psoriasis patients achieved clear or almost clear skin (PASI 90) compared to Stelara®

- Phase IIIb CLEAR study at AAD showed over 21% more psoriasis patients achieved clear to almost clear skin (PASI 90) with Cosentyx (secukinumab) compared to Stelara® (ustekinumab) at Week 16 - In assessing superiority, a higher percentage of ...
 FiercePharmaMarketing1 day ago Novartis Cosentyx(TM) two-year data shows sustained effect and favorable safety profile in psoriasis patients  Pharma Voice3 days ago New Novartis data shows Cosentyx(TM) is significantly superior to Stelara® and clears skin (PASI 90) in nearly 80% of psoriasis patients  Nasdaq6 days ago Novartis' Cosentyx(TM) two-year data shows sustained effect and favorable safety profile in psoriasis patients  Yahoo! UK and Ireland5 days ago
[x]  
Reuters

Boehringer Ingelheim's investigational biologic cleared skin better than ustekinumab in head-to-head Phase II psoriasis study

Nearly double the percentage of patients on BI 655066 with clear or almost clear skin (PASI 90) after 12 weeks vs. ustekinumab1 BI 655066 selectively blocks IL-23, a key protein involved in psoriatic skin inflammation1 SAN FRANCISCO, Calif. - ...
 FiercePharmaMarketing1 day ago BOEHRINGER INGELHEIM : 's investigational biologic cleared skin better than ustekinumab in head-to-head Phase II psoriasis study  4 Traders6 days ago Boehringer announces encouraging data from Phase II plaque psoriasis study  Individual.com1 day ago Boehringer reports positive results from Phase II psoriasis trial  Pharmaceutical Business Review3 days ago
[x]  
World Connector Net

Positive Results from Phase III Study Evaluating Oral OTEZLA® (Apremilast) or Injectable Etanercept versus Placebo in Patients with Moderate to Severe Plaque Psoriasis Presented at AAD

More patients achieved a PASI-75 response at week 32 than at week 16 for those randomized to OTEZLA at baseline and those switched from etanercept to OTEZLA at week 16 In a post-hoc analysis of PASI-75 at week 16, there was no statistically ...
 Libya Business Info5 days ago Oral OTEZLA® (apremilast) Lon ...  World Connector Net3 days ago Positive Results from Phase I ...  World Connector Net3 days ago Celgene Updates on Positive Results from Phase III Study Evaluating Oral OTEZLA (Apremilast)  Individual.com1 day ago
[x]  

High-Dose Brodalumab Superior to Ustekinumab in Helping Patients With Psoriasis Reach PASI 100: Presented at AAD

You currently are not registered for any FirstWord Pharma services. Register to FirstWord Pharma for free access to 10 articles every 30 days: You can also: Wait 24 days for your content allowance to be renewed. Sign up for a free trial to ...
 FirstWord Pharma2 days ago
Education News

The tower of PISA is badly leaning. An argument for why it should be saved.

Mar 24, 2015 by By Pasi Sahlberg and Andy Hargreaves What if three-quarters of American school students voluntarily attended daily after-school classes to boost their knowledge of mathematics, literacy, and science? On top of ...
 Education News2 days ago Strauss: The tower of PISA is badly leaning. An argument for why it should be saved.  Washington Post2 days ago

Passi City celebrates Pintados 2015

PASSI City Pintados de Pasi is a colorful celebration that depicts the history of Passi City and the way of life of its people through the pintados performers adorned with traditional body tattoos. Today, five groups will compete in this year's ...
 Panay News5 days ago Passi celebrates recovery from Yolanda  Panay News4 days ago
Borneo Post Online

Tangguh activiti pembakaran terbuka pada musim panas

TERBAKAR: Satu kebakaran rumput berlaku di Jalan Wah Yee, Sungai Pasi dekat Sarikei, petang kelmarin. SARIKEI: Masyarakat harus menang-guhkan aktiviti pembakaran terbuka, kata Pegawai Bomba dan Penyelamat Sarikei Haron Jenai. Jelasnya, amaran ...
 Borneo Post Online4 days ago

Valmet's Capital Markets Day 2015 in London tod...

At the event President and CEO Pasi Laine will tell more about the acquisition of Process Automation Systems business. Automation will become Valmet's fourth business line. The completion of the transaction is subject to approval by the competition ...
 MoneyAM1 week ago Valmet''s Capital Markets Day 2015 in London today on March 19, 2015  Nasdaq1 week ago REG-Valmet's Capital Markets Day 2015 in London today on March 19, 2015  Reuters1 week ago Valmet : Capital Markets Day 2015 in London today on March 19, 2015  4 Traders1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - pasi
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less